CRISPR Therapeutics (CRSP) proposes to elect Briggs Morrison, M.D., to its Board of Directors at the Company’s annual general meeting to be held this year. Morrison currently serves as CEO and as a member of the Board of Directors of Crossbow Therapeutics.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRSP:
- Crispr Therapeutics price target lowered to $85 from $98 at BofA
- Crispr Therapeutics call volume above normal and directionally bullish
- Cathie Wood’s ARK Investment bought 58K shares of Crispr Therapeutics today
- Crispr Therapeutics presents data on CTX112 at ASH Meeting
- Biotech Alert: Searches spiking for these stocks today